What is Central Retinal Vein Occlusion (CRVO)?
Central Retinal Vein Occlusion (CRVO) is a blockage in the main vein of the retina, leading to vision problems. Symptoms may include sudden blurring or loss of vision, distortion, or seeing “floaters.” This condition requires prompt medical attention to prevent further vision impairment.
Causes and Risk Factors
Several factors can contribute to the development of CRVO, including:
- High Blood Pressure: Uncontrolled hypertension can damage blood vessels in the retina.
- Diabetes: High blood sugar levels can lead to vascular complications in the eye.
- Smoking: Smoking is a significant risk factor that can worsen CRVO and hinder treatment effectiveness.
- Other Medical Conditions: Conditions such as glaucoma or hyperlipidemia can also increase the risk.
Common Symptoms
Symptoms of CRVO may include:
- Sudden blurring or loss of vision
- Distortion of vision
- Seeing “floaters” (small specks or spots in your vision)
Support and Resources
Living with or being at risk for CRVO can be challenging, but there are resources available:
- Healthcare Provider: Regular consultations with an eye specialist for early detection and treatment.
- Support Groups: Connecting with others who have similar conditions can provide valuable support and information.
- Educational Resources: Access to information about managing CRVO and its risk factors can help manage the condition.
How We Can Help
Retina Care Group offers comprehensive care for patients with CRVO, including:
- Diagnosis and Monitoring: Routine eye exams and advanced diagnostic tools to detect and monitor CRVO.
- Treatment Options: Effective treatment options include:
- Avastin (Bevacizumab) Injections: Avastin is a medication used to treat CRVO by reducing abnormal blood vessel growth. Injections are administered directly into the eye, and the frequency may vary depending on the individual’s response to treatment.
- Eylea (Aflibercept) Injections: Eylea is another medication used to treat CRVO by blocking abnormal blood vessel growth. Like Avastin, Eylea injections are given directly into the eye, and the frequency may vary depending on the individual’s response to treatment.
- Before the Injection: The eye is numbed with drops to minimize discomfort, and the area is cleaned to prevent infection. Patients should inform their doctor about any allergies or medications they are taking.
- During the Injection: The injection is quick and may cause a temporary sensation of pressure or mild discomfort.
- After the Injection: The eye may feel slightly irritated or watery for a short time. Vision may be blurry immediately after the injection but should improve within a few days.
- Follow-up Visits: Regular follow-up appointments are essential to monitor the patient’s response to treatment. Any changes in vision or unusual symptoms should be reported to the doctor promptly.
- Lifestyle Management: Emphasizing the importance of maintaining a healthy lifestyle with regular exercise, a balanced diet, controlling blood pressure and blood sugar levels, and avoiding smoking to reduce the risk of complications.
Summary
Central Retinal Vein Occlusion (CRVO) is a serious condition that can significantly impact vision if not managed properly. Recognizing the symptoms and seeking regular medical attention are crucial. With the right support and resources, including treatments available at Retina Care Group, individuals can effectively manage CRVO and maintain their vision. If you have any questions or concerns, don’t hesitate to discuss them with your eye doctor.